Skip to main content
Log in

The Ishikawa cells from birth to the present

  • Review
  • Published:
Human Cell Aims and scope Submit manuscript

Abstract

More than 20 years have passed since the Ishikawa cell line, a well-differentiated human endornetrial adenocarcinoma cell line, was established. Because this cell line bears estrogen and progesterone receptors, the cells have been used in numerous basic research areas such as reproductive biology and molecular science, and has been distributed to more than a hundred institutes. However, even the Ishikawa cells, after long-term culture, tend to transform into undifferentiated cells. In addition, it has been reported that estrogen and progesterone receptors disappeared from the cells that I distributed. I therefore attempted to establish well-differentiated cells from the parent Ishikawa cells and to produce a new and good quality supply of this cell line. I believe that it is very important for the investigator who established a cell line to be responsible for maintaining the quality of the cells. That is why I have not deposited this cell line in any cell bank.

I would like to take this opportunity to report the history of Ishikawa cells from establishment to the present.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nishida, M., Kasahara, K., Kaneko, M., Iwasaki, H., and Hayashi, K. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obst. Gynuec. Jpn. 1985; 37: 1103–1111.

    CAS  Google Scholar 

  2. Kuramoto, H., Tamura, S., Notake, Y.: Establishment of a cell line of human endometrial adenecarcinoma in vitro. Am J Obstet Gynecol 1972; 114: 1012–1019.

    CAS  PubMed  Google Scholar 

  3. McGuire, W. L., DeLaGarza, M.: Improved sensitivity in the measurement of estrogen receptor in human breast cancer. J Clin Endocrinol Metab 1973; 37: 986–989.

    Article  CAS  PubMed  Google Scholar 

  4. Nishida, M., Kasahara, K., Oki, A., Satoh, T., Arai, Y., Kubo, T. Establishment of eighteen clones of Ishikawa cells. Human Cell 1996; 9: 109–116.

    CAS  PubMed  Google Scholar 

  5. McCarty, K.S. Jr., Barton, T.K., Fetter, B.F., Creasman, W.T., and McCarty, K.S. Sr. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. Am. J Puthol. 1979; 96: 171–182.

    Google Scholar 

  6. Creasman, W.T., McCarty, K.S. Sr., Barton, T.K., and McCarty, K.S. Jr. Clinical correlates of estrogen and progesterone-binding in human endometrial adenocarcinoma. Obstet. Gynecol. 1980; 55: 363–370.

    CAS  PubMed  Google Scholar 

  7. Ehrlich, C.E., Young, P.C.M., and Cleary, R.E. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implications. Am. J. Obstet. Gynecol. 1981; 141: 539–546.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishida, M. The Ishikawa cells from birth to the present. Hum Cell 15, 104–117 (2002). https://doi.org/10.1111/j.1749-0774.2002.tb00105.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1749-0774.2002.tb00105.x

Key words

Navigation